Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies.

Unger JM, Andrews HS, Levit LA, McKelvey BA, Stewart M, Canin B, Flaherty K, Kimball D, Miller T, Onitilo A, Bruinooge S, Garrett-Mayer E, Schenkel C

Open source

DOI
10.1200/oa-25-00021
Published
2025 Jun
Container
JCO oncology advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/oa-25-00021,
  title = {Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies.},
  author = {Unger JM and Andrews HS and Levit LA and McKelvey BA and Stewart M and Canin B and Flaherty K and Kimball D and Miller T and Onitilo A and Bruinooge S and Garrett-Mayer E and Schenkel C},
  year = {2025},
  journal = {JCO oncology advances},
  doi = {10.1200/oa-25-00021},
  url = {https://doi.org/10.1200/oa-25-00021}
}

RIS

TY  - JOUR
TI  - Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies.
AU  - Unger JM
AU  - Andrews HS
AU  - Levit LA
AU  - McKelvey BA
AU  - Stewart M
AU  - Canin B
AU  - Flaherty K
AU  - Kimball D
AU  - Miller T
AU  - Onitilo A
AU  - Bruinooge S
AU  - Garrett-Mayer E
AU  - Schenkel C
PY  - 2025
JO  - JCO oncology advances
DO  - 10.1200/oa-25-00021
UR  - https://doi.org/10.1200/oa-25-00021
ER  - 

APA

JM, U., HS, A., LA, L., BA, M., M, S., B, C., K, F., D, K., T, M., A, O., S, B., E, G., & C, S. (2025). Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies.. JCO oncology advances. https://doi.org/10.1200/oa-25-00021

Source records